Table 2.
Data of patients with TINU syndrome
| Characteristics | N | Values |
|---|---|---|
| Gender (male:female), n (%) | 71 | 28 (39):43 (61) |
| Age (years), median (IQR) | 71 | 42 (18–55) |
| Pathogeny (s), n (%) | 39 | |
| None | 27 (69) | |
| Infection | 11 (28) | |
| Drugs | 1 (3) | |
| Prodromal symptoms, n (%) | 71 | |
| Fever | 48 (68) | |
| Fatigue | 54 (76) | |
| Gastrointestinal symptoms | 40 (56) | |
| Increased nocturia | 11 (15) | |
| Eye symptoms, n (%) | 71 | |
| Redness | 33 | 26 (79) |
| Eye pain | 44 (62) | |
| Blurred vision | 43 (61) | |
| Photophobia | 27 (38) | |
| Uveitis, n (%) | 71 | |
| Anterior uveitis | 39 (55) | |
| Intermediate uveitis | 9 (13) | |
| Panuveitis | 7 (10) | |
| None | 16 (23) | |
| Uveitis (unilateral:bilateral), n (%) | 71 | 15 (21):53 (75) |
| Uveitis onset, n (%) | 70 | |
| Before renal involvement | 11 (16) | |
| Concurrent renal involvement | 21 (30) | |
| After renal involvement | 38 (54) | |
| Urinary abnormalities, n (%) | ||
| Proteinuria | 37 | 34 (92) |
| Glycosuria | 33 | 27 (82) |
| Microscopic hematuria | 32 | 7 (22) |
| Treatment | 71 | |
| Glucocorticoid alone | 47 (66) | |
| Glucocorticoid + immunosuppressant | 22 (31) | |
| Other | 2 (3) | |
| The data of follow-up > 6 months | 51 | |
| Months, median (IQR) | 24 (12–36) | |
| Recurrence of uveitis or Chronic uveitis, n (%) | 24 (47) | |
| Recurrence of kidney disease or Chronic kidney disease, n (%) | 42 | 20 (48) |